Transaction DateRecipientSharesTypePriceValue
30th June 2020Arthur J Klausner323Exercise of derivative$0.00
30th June 2020Christopher M Starr323Exercise of derivative$0.00
30th June 2020Raymond Anderson323Exercise of derivative$0.00
30th June 2020Michael J Brown323Exercise of derivative$0.00
16th June 2020Michael J Brown20,000Bona fide gift$0.00
12th June 2020Michael J Brown85,000Bona fide gift$0.00
31st March 2020Christopher M Starr322Exercise of derivative$0.00
31st March 2020Raymond Anderson322Exercise of derivative$0.00
31st March 2020Michael J Brown322Exercise of derivative$0.00
31st March 2020Arthur J Klausner322Exercise of derivative$0.00
Monopar Therapeutics
Monopar Therapeutics logo

Monopar Therapeutics, Inc. engages in developing orphan oncology drugs. The company was founded by Chandler D. Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014.


Ticker: MNPR
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1645469
Employees: 7
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals